|
|||||
|
Dear Subscribers,
Sponsor
For Once, We Agree With Wall Street: This WILL "Outperform" Japan, Libya and budget woes dominate the news, obscuring key market signals - and opportunities. Example: Healthcare analysts from two major Wall St. firms both just upgraded one tiny stock to "Outperform" based on a landmark FDA ruling. For once, we agree with Wall Street. This stock is poised to positively explode. Shares remain wildly undervalued at under $7, but the timing here is critical. Go here now for details. And do not delay.
Today's Top Stories: Wednesday- May 11, 2011
ZACKS RANK BUY STOCKS
Learn how to profit from our exclusive Zacks Rank stock-ranking system with free resources. Read More... ZACKS MUTUAL FUND RANK
BEST OF ZACKS EQUITY RESEARCH
Sponsor
GET THIS SUMMER'S 5 MUST-LEARN STOCK SECRETS NEW ZACKS VIDEOS:
EDUCATION: Aggressive Growth
PeopleAndPicks.com:
FACEBOOK
TWITTER OTHER ZACKS RESOURCES:
Manage your Profit from the Pros subscription:
REFER-A-FRIEND
If you enjoy this e-mail newsletter, then please pass it along to a friend. Simply forward them the link below to sign up for their own free subscription. THANKS! Best,
Steve Reitmeister p.s. What is the mission for Zacks Profit from the Pros? To find out how we will help you become a more successful investor, click here. |
|||||
|
Visit /performance for information about the performance numbers displayed in this newsletter. Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security. To contact us by mail:
Zacks Investment Research
To unsubscribe from receiving "Zacks.com Profit from the Pros" |
|||||
